Article
TAK1 blockade as a therapy for retinal neovascularization
2021-01-29
Abstract excerpt
<h4>ABSTRACT</h4> Retinal neovascularization, or pathological angiogenesis in the retina, is a leading cause of blindness in developed countries. Transforming growth factor-β-activated kinase 1 (TAK1) is a mitogen-activated protein kinase kinase kinase (MAPKKK) activated by TGF-β1 and other pro-inflammatory cytokines. TAK1 is also a key mediator of inflammation, innate immune responses, apoptosis and tissue homeo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ada32dcd-3d15-5a94-977e-7451f7e7e680
- DOI
- 10.1101/2021.01.29.428701
